Pharmacist-led Continuous Glucose Monitoring
NCT: NCT06572306 · RECRUITING
Brief Summary
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)
Frequently Asked Questions
What is Pharmacist-led Continuous Glucose Monitoring?
Pharmacist-led Continuous Glucose Monitoring is a clinical trial registered under NCT06572306. Current status: RECRUITING.
What is the status of NCT06572306?
The current status of NCT06572306 (Pharmacist-led Continuous Glucose Monitoring) is: RECRUITING.
When did Pharmacist-led Continuous Glucose Monitoring start?
Pharmacist-led Continuous Glucose Monitoring started on 2024-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.